Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Joseph Fritzky

Pediatrics Randolph, NJ Medical Doctor

NPI 1528568698 CMS profile 7562347

College Plaza Pediatrics, 165 Route 10 East, Suite 203, Randolph, NJ 07869

Open in the dashboard

General payments

$3,783

236 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Joseph Fritzky of Randolph, NJ is reported in the CMS Open Payments database as having received $3,783 across 236 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $638 41
2024 General $780 48
2023 General $771 40
2022 General $741 48
2021 General $601 42
2020 General $253 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Fritzky
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Joseph Fritzky were reported at $638. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Joseph Fritzky Pediatrics median Middle half National median
2019 $0 $86 $31–$183 $163
2020 $253 $49 $22–$110 $114
2021 $601 $68 $27–$158 $132
2022 $741 $77 $30–$173 $149
2023 $771 $88 $33–$190 $160
2024 $780 $94 $34–$206 $164
2025 $638 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. GlaxoSmithKline, LLC. $449 15 payments
  2. Tris Pharma Inc $365 23 payments
  3. Corium, Inc. $314 20 payments
  4. kaleo, Inc. $304 21 payments
  5. Merck Sharp & Dohme Corporation $260 18 payments
  6. Supernus Pharmaceuticals, Inc. $248 15 payments
  7. Neos Therapeutics, LP $226 18 payments
  8. Cranial Technologies, Inc $180 11 payments
  9. Pfizer Inc. $177 12 payments
  10. Sanofi Pasteur Inc. $156 8 payments
  11. Other $1,104 75 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $3,783 236 payments
Products named General payments · program years 2020–2025
  1. BEXSERO $449 15 payments
  2. Azstarys $314 20 payments
  3. AUVI-Q $287 20 payments
  4. GARDASIL 9 $260 18 payments
  5. VAXELIS $223 15 payments
  6. Dyanavel XR Adhd $202 11 payments
  7. Doc Band $180 11 payments
  8. QELBREE $176 11 payments
  9. Dyanavel XR Adhd $163 12 payments
  10. NEFFY $153 12 payments
  11. Other $2,731 176 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

236 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record